Clinical Trials Insight: 700021549
Phase of Trial: Phase II
Latest Information Update: 21 May 2009
At a glance
- Drugs Vadimezan (Primary) ; Carboplatin; Paclitaxel
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors Antisoma
- 21 May 2009 Results have been published in the journal Lung Cancer, according to an Antisoma media release.
- 01 Jun 2008 Results presented at ASCO 2008.
- 13 Sep 2007 Status changed from in progress to completed.